Corcept Therapeutics’ Post

👉We are in a new exciting era for #obesity pharmacotherapy, where #GLP1RA drugs approach the #weightloss achieved with #bariatricsurgery. 👉There is growing momentum and excitement for the expanded use of GLP-1 RA drugs beyond #diabetes and #obesity. 👉The key finding of much less weight loss in the new trial with type 2 diabetes helps us understand the story of GLP-1's success, and it's not just because of reduced body weight. 👉 The results of the GLP-1 RA trials have sparked a lot of interest, particularly in #Parkinson's disease, #Alzheimer's disease, and #Heartfailure with preserved ejection fraction. 👉The GLP-1 family of drugs has also been shown to have positive effects in preventing #kidneydamage in diabetes, #liverdiseases (non-alcoholic or metabolic-associated steatosis, NASH/MASH), and #addiction.

Discover why Mounjaro is making waves in weight loss and diabetes management. This groundbreaking drug offers a new hope with its unique dual-action mechanism, targeting both GLP-1 and GIP receptors for effective weight control. Dive into our detailed exploration of Mounjaro's potential, from its innovative approach to weight loss to its promising clinical trial results. Whether you're seeking an effective diabetes treatment or a novel weight loss solution, Mounjaro's story is one you'll want to follow. Read more about how this new drug could revolutionize the approach to managing obesity and type 2 diabetes. Full Article: https://lnkd.in/gdiCR-St #Mounjaro #WeightLossJourney #DiabetesManagement #GLP1GIP #ObesitySolutions #Type2Diabetes #HealthInnovation #MedicalBreakthrough #WeightManagement #HealthyLiving #DiabetesCare #ChronicIllness #MetabolicHealth #LifestyleChange #Pharmacotherapy

What Effects Did Stress Have on Your Body? #semaglutide #weightloss #ozempic Introduction to semaglutide: Semaglutide is introduced as a once-a-week injection that helps with weight loss. It is considered a promising medication for addressing obesity and associated health concerns. semaglutide journey: Semaglutide is classified as a GLP-1 receptor agonist, originally approved for the treatment of diabetes in 2005. What is the dark side of semaglutide?

As reported by CNBC according to long-term trial results, Eli Lilly and Company's weight loss drug, tirzepatide, 𝐬𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐭𝐥𝐲 𝐫𝐞𝐝𝐮𝐜𝐞𝐝 𝐭𝐡𝐞 𝐫𝐢𝐬𝐤 𝐨𝐟 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐢𝐧𝐠 𝐓𝐲𝐩𝐞 𝟐 𝐝𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐢𝐧 𝐨𝐯𝐞𝐫𝐰𝐞𝐢𝐠𝐡𝐭 𝐨𝐫 𝐨𝐛𝐞𝐬𝐞 𝐚𝐝𝐮𝐥𝐭𝐬 𝐰𝐢𝐭𝐡 𝐩𝐫𝐞𝐝𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐛𝐲 𝟗𝟒%. The drug also demonstrated sustained weight loss over three years, highlighting its potential to delay diabetes diagnosis and improve overall health. Two questions: ▫ What's your company's GLP-1 strategy? ▫ As obesity is linked to numerous metabolic disorders, should your company consider GLP-1 usage outside of those with diabetes? #DiabetesPrevention #WeightLoss #Tirzepatide #HealthcareInnovation #EliLilly

Have you used Ozempic, Wegovy, or Mounjaro? These medications for type 2 diabetes and weight loss have been associated with serious health issues such as intraoperative pulmonary aspiration, pancreatic cancer, severe or permanent stomach paralysis, gastroparesis, and other gastrointestinal injuries. If you or a loved one has experienced one of these conditions after using any of these medications, contact us for a free case review. Read our new blog to learn more: https://lnkd.in/eezKysmy

Check out my latest article on MedBound Times: "Growing Demand for GLP-1 RAs: Diabetes and Weight Loss." Explore how these innovative therapies are changing the landscape of diabetes treatment and weight management! MedBound Times MedBound

Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes: Target Trial Emulation Using Real-World Data « The study compared 222 942 new users of antidiabetes medications including 5967 of semaglutide. Semaglutide was associated with a significantly lower risk for medical encounters for TUD diagnosis compared with other antidiabetes medications, and was strongest compared with insulins (hazard ratio [HR], 0.68 [95% CI, 0.63 to 0.74]) and weakest but statistically significant compared with other GLP-1RAs (HR, 0.88 [CI, 0.81 to 0.96]). Semaglutide was associated with reduced smoking cessation medication prescriptions and counseling. Similar findings were observed in patients with and without a diagnosis of obesity. For most of the group comparisons, the differences occurred within 30 days of prescription initiation » #semaglutide #tobacco #GLP1 #Diabetes #smoking #publichealth #RWE https://lnkd.in/eV9WTN66

What Effects Did Stress Have on Your Body? #ozempic #semaglutide #weightloss #muscles #fatloss #transformation #bodyfatpercentage #fatburner #musclebuilding Introduction to semaglutide: Semaglutide is introduced as a once-a-week injection that helps with weight loss. It is considered a promising medication for addressing obesity and associated health concerns. semaglutide journey: Semaglutide is classified as a GLP-1 receptor agonist, originally approved for the treatment of diabetes in 2005. semaglutide weight loss reviews: It is mentioned that Semaglutide has demonstrated significant weight loss benefits in clinical studies, not only improving blood sugar control but also leading to substantial weight loss.

🟣 Sevelamer Review. Sevelamer is a drug used as a phosphate binder in patients with hyperphosphatemia due to chronic kidney disease (CKD). 🔸In patients with CKD, sevelamer has also been shown to reduce LDL cholesterol. Mechanism. Sevelamer has amine groups which become partially protonated in the intestine. This then interacts with and binds phosphate through both hydrogen bonding and ionic bonding. Side Effects. ☑️ nausea and vomiting ☑️ constipation or diarrhea ☑️ stomach pain ☑️ heartburn ☑️ gas ⚠️Contraindicated in hypophosphatemia or bowel obstruction. Brands. 🔸 Renagel 🔸 Renvela #Renagel #Renvela #Newdrug #pharmacy

Dysregulated aldosterone production is an under-recognized cause of #hypertension, and mounting evidence points towards obesity as a leading culprit. Learn more about how directly reducing aldosterone synthesis may help in treating uncontrolled hypertension in Healio. #BloodPressureControl #HealthcareInnovation